HC
PTCT icon

Henshaw Capital’s PTC Therapeutics PTCT Stock Holding History

Henshaw Capital’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,460
Closed -$257K – 288
2023
Q3 		$257K Buy
11,460
+4,261
+59% +$158K 0.01% 247
2023
Q2 		$293K Buy
7,199
+958
+15% +$46.9K 0.02% 189
2023
Q1 		$302K Buy
6,241
+703
+13% +$32.1K 0.02% 177
2022
Q4 		$211K Hold
5,538
– – 0.01% 227
2022
Q3 		$278K Hold
5,538
– – 0.02% 213
2022
Q2 		$222K Hold
5,538
– – 0.02% 277
2022
Q1 		$207K Hold
5,538
– – 0.01% 307
2021
Q4 		$221K Hold
5,538
– – 0.01% 311
2021
Q3 		$206K Hold
5,538
– – 0.01% 317
2021
Q2 		$234K Hold
5,538
– – 0.01% 322
2021
Q1 		$262K Buy
5,538
+783
+16% +$46.5K 0.02% 302
2020
Q4 		$290K Buy
+4,755
New +$280K 0.02% 262

Other funds holding PTCT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
CAC
Cowen and Company New York $2.9B AUM 105.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return